Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer

Published:2020-12 Issue:12 Volume:40 Page:7067-7075
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

FUJII HIRONORI,MAKIYAMA AKITAKA,IIHARA HIROTOSHI,OKUMURA NAOKI,YAMAMOTO SENRI,IMAI TAKEHARU,ARAKAWA SHINICHIRO,KOBAYASHI RYO,TANAKA YOSHIHIRO,YOSHIDA KAZUHIRO,SUZUKI AKIO

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy;Journal of Pharmaceutical Health Care and Sciences;2024-07-10

2. CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism;International Journal of Clinical Oncology;2024-05-22

3. Influence of cachexia on immunotherapy efficacy and prognosis for malignant tumors of the digestive system;Cancer Reports;2024-05

4. Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database;Supportive Care in Cancer;2024-03-26

5. Impact of hypoglycemia after gastrectomy on Global Leader Initiative on Malnutrition-defined malnutrition: a retrospective study;Surgery Today;2024-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP